A new transmucosal fentanyl for breakthrough cancer pain.
Rospond
R M
RM
Drake University, College of Pharmacy and Health Sciences, Des Moines, Iowa, USA.
D000284:Administration, Oral; D000701:Analgesics, Opioid / Q000494:pharmacology / Q000627:therapeutic use*; D005283:Fentanyl / Q000494:pharmacology / Q000627:therapeutic use*; D006801:Humans; D009369:Neoplasms / Q000150:complications*; D010146:Pain / Q000188:drug therapy* / Q000209:etiology
D000701:Analgesics, Opioid; D005283:Fentanyl